Skip to content

Event log

The following is a list of all job requests run via OpenSAFELY.
Status Project Workspace User Jobs Backend Started View request
Succeeded Bennett Institute Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 prophy_effects_sotro_molnup Qing Wen 2/2 TPP 2 hours ago 04 May 2024 08:58:36 UTC View
Running The London School of Hygiene & Tropical Medicine Long-term kidney outcomes after SARS-CoV-2 infection long_term_kidney_outcomes_after_covid Viyaasan Mahalingasivam 38/45 TPP 2 hours ago 04 May 2024 08:33:36 UTC View
Failed The London School of Hygiene & Tropical Medicine Long-term kidney outcomes after SARS-CoV-2 infection long_term_kidney_outcomes_after_covid Viyaasan Mahalingasivam 49/52 TPP 11 hours ago 04 May 2024 00:01:50 UTC View
Failed The London School of Hygiene & Tropical Medicine Long-term kidney outcomes after SARS-CoV-2 infection long_term_kidney_outcomes_after_covid Viyaasan Mahalingasivam 1/50 TPP 03 May 2024 at 23:49 03 May 2024 23:49:50 UTC View
Succeeded Bennett Institute Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 prophy_effects_sotro_molnup Qing Wen 1/1 TPP 03 May 2024 at 21:10 03 May 2024 21:10:39 UTC View
Succeeded Bennett Institute Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 prophy_effects_sotro_molnup Qing Wen 1/1 TPP 03 May 2024 at 20:56 03 May 2024 20:56:42 UTC View
Succeeded University of Bristol Investigating events following SARS-CoV-2 infection post-covid-autoimmune-v3 Michael Gulley 15/15 TPP 03 May 2024 at 17:08 03 May 2024 17:08:27 UTC View
Succeeded University of Bristol Investigating events following SARS-CoV-2 infection post-covid-autoimmune-v3 Michael Gulley 1/1 TPP 03 May 2024 at 14:37 03 May 2024 14:37:20 UTC View
Succeeded University of Bristol Investigating events following SARS-CoV-2 infection post-covid-autoimmune-v3 Michael Gulley 14/14 TPP 03 May 2024 at 16:40 03 May 2024 16:40:45 UTC View
Succeeded University of Bristol Investigating events following SARS-CoV-2 infection post-covid-autoimmune-v3 Michael Gulley 12/12 TPP 03 May 2024 at 16:21 03 May 2024 16:21:01 UTC View
Succeeded University of Bristol Investigating events following SARS-CoV-2 infection post-covid-autoimmune-v3 Michael Gulley 9/9 TPP 03 May 2024 at 14:47 03 May 2024 14:47:46 UTC View
Succeeded University of Bristol Investigating events following SARS-CoV-2 infection post-covid-autoimmune-v3 Michael Gulley 9/9 TPP 03 May 2024 at 14:32 03 May 2024 14:32:03 UTC View
Succeeded University of Bristol Investigating events following SARS-CoV-2 infection post-covid-autoimmune-v3 Michael Gulley 9/9 TPP 03 May 2024 at 14:30 03 May 2024 14:30:53 UTC View
Succeeded Bennett Institute Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 prophy_effects_sotro_molnup Qing Wen 2/2 TPP 03 May 2024 at 12:02 03 May 2024 12:02:35 UTC View
Succeeded University of Bristol Investigating events following SARS-CoV-2 infection post-covid-mentalhealth-v3 Venexia Walker 2/2 TPP 03 May 2024 at 11:41 03 May 2024 11:41:14 UTC View
Succeeded University of Bristol Investigating events following SARS-CoV-2 infection post-covid-autoimmune-v3 Michael Gulley 6/6 TPP 03 May 2024 at 12:18 03 May 2024 12:18:52 UTC View
Succeeded University of Bristol Investigating events following SARS-CoV-2 infection post-covid-autoimmune-v3 Michael Gulley 15/15 TPP 03 May 2024 at 11:46 03 May 2024 11:46:05 UTC View
Succeeded University of Bristol Investigating events following SARS-CoV-2 infection post-covid-autoimmune-v3 Michael Gulley 8/8 TPP 03 May 2024 at 11:14 03 May 2024 11:14:56 UTC View
Succeeded University of Bristol Investigating events following SARS-CoV-2 infection post-covid-autoimmune-v3 Michael Gulley 12/12 TPP 03 May 2024 at 11:05 03 May 2024 11:05:07 UTC View
Succeeded University of Bristol Investigating events following SARS-CoV-2 infection post-covid-autoimmune-v3 Michael Gulley 9/9 TPP 03 May 2024 at 10:11 03 May 2024 10:11:48 UTC View
Succeeded University of Bristol Investigating events following SARS-CoV-2 infection post-covid-autoimmune-v3 Michael Gulley 9/9 TPP 03 May 2024 at 10:00 03 May 2024 10:00:11 UTC View
Succeeded University of Bristol Investigating events following SARS-CoV-2 infection post-covid-autoimmune-v3 Michael Gulley 9/9 TPP 03 May 2024 at 09:59 03 May 2024 09:59:01 UTC View
Succeeded The London School of Hygiene & Tropical Medicine The healthcare utilisation of people with long COVID - OpenPROMPT healthcare_utilisation_openprompt Liang-Yu Lin 1/1 TPP 02 May 2024 at 15:12 02 May 2024 15:12:00 UTC View
Succeeded The London School of Hygiene & Tropical Medicine Long-term kidney outcomes after SARS-CoV-2 infection long_term_kidney_outcomes_after_covid Viyaasan Mahalingasivam 1/1 TPP 02 May 2024 at 15:08 02 May 2024 15:08:20 UTC View
Succeeded The London School of Hygiene & Tropical Medicine Long-term kidney outcomes after SARS-CoV-2 infection long_term_kidney_outcomes_after_covid Viyaasan Mahalingasivam 1/1 TPP 02 May 2024 at 14:36 02 May 2024 14:36:42 UTC View